GlassScriptPhysician profile
Donna M Alfieri
NPI 1457324493
$2,637.92
in general payments reported to CMS, 2019-2025
17 companies · $465 in 2025
The $465 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $128 · 2021: $304 · 2022: $224 · 2023: $598 · 2024: $556 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,481 · Education: $117 · Travel and Lodging: $21.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,481.01 |
| Education | $116.82 |
| Travel and Lodging | $21.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $439.11 | 2021-2024 | Dalvance |
| Kerecis Limited | $429.68 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Advanced Oxygen Therapy INC. | $288.36 | 2019-2024 | Topical Oxygen Chamber For Extremities |
| Organogenesis INC. | $203.08 | 2021-2025 | Via Matrix |
| Medtronic, INC. | $181.23 | 2023-2024 | Intellis Adaptivestim |
| Abbott Laboratories | $164.55 | 2019 | |
| Next Science LLC | $144.94 | 2023 | Blastx, Xperience, Surgx |
| Lifenet Health | $139.60 | 2025 | Theragenesis Wound Matrix |
| Horizon Therapeutics Plc | $127.87 | 2020 | |
| Paratek Pharmaceuticals, INC. | $124.54 | 2021 | |
| Amgen INC. | $110.77 | 2025 | Krystexxa |
| Grt US Holding, INC. | $89.83 | 2022 | |
| Intercept Pharmaceuticals, INC. | $67.52 | 2023-2024 | Ocaliva |
| Averitas Pharma INC. | $58.00 | 2023 | Qutenza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $33.83 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $19.26 | 2022 | |
| Merck Sharp & Dohme LLC | $15.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Alfieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.